Tuesday, October 7, 2025

Bright Minds: Focusing On Second Generation Psychedelic Compounds – The Daily Dive

Starting off this week on the Daily Dive is that of Dr Gideon Shapiro, whom is VP of Discovery at Bright Minds Biosciences (CSE: DRUG). A leading scientist in the field of creating novel psychedelics to treat mental health disorders, Dr Shapiro joins us this afternoon to provide us with a deeper understanding of seratonin and novel psychedelics, while also discussing the current pipeline, the development of second generation psychedelic compounds, and how Bright Minds’ approach differs from its peers.

Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation serotonin agonists designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. The Company is developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious drugs.


FULL DISCLOSURE: Bright Minds Biosciences is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Bright Minds Biosciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Core Assets Corp Gears Up for 2023 Drilling Season — With Nick Rodway

Joining us today on the Daily Dive is Nick Rodway, CEO, President & Director of...

Tuesday, April 4, 2023, 01:30:00 PM

How OPEC+’s Surprise Cut Impacts Oil Prices & Everyday Consumers — With Mike McGlone

Back on the Daily Dive today is Mike McGlone, a Bloomberg Intelligence senior commodity strategist....

Wednesday, April 5, 2023, 01:30:00 PM

Costco Gold Sales: Middle Class Turning to Precious Metals? With David Garafolo of Gold Royalty Corp

In this interview, David Garofalo, CEO & Chairman of Gold Royalty Corp. (NYSE: GROY), provides...

Tuesday, October 15, 2024, 04:00:00 PM

NFT’s: Understanding The Purpose For Non-Fungible Tokens – The Daily Dive feat David Yu

Joining us today for the first episode of the trading week, is that of David...

Monday, July 5, 2021, 01:30:00 PM

Gold: Is A Breakout About To Happen? – The Daily Dive

We have a returning guest on the Daily Dive today in Gareth Soloway of InTheMoneyStocks.com....

Tuesday, February 8, 2022, 01:30:00 PM